← TAKEDA PHARMACEUTICAL CO LTD

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 TTM
Cash flows from operating activities:
Net Income — — — — — — $317.0b
$144.1b -54.56%
$107.9b -25.08%
($152.4b) -241.20%
$137.1b +189.98%
Net Income From Continuing Operations — — — — — — $317.0b $144.2b $108.1b ($152.1b) $137.1b
Profit or Loss — — $109.0b $44.3b $376.2b $230.2b $317.0b $144.2b $108.1b — —
Depreciation and amortization $171.4b $182.1b $272.4b $583.6b $559.7b $583.2b $664.4b $728.0b $761.4b $721.1b $750.8b
Depreciation Amortization Depletion — — — — — — $664.4b $728.0b $761.4b $721.1b $750.8b
Deferred Income Tax $27.8b $30.5b $14.1b $105.0b $9.9b $72.4b $58.1b ($91.4b) $66.9b $9.8b $52.0b
Deferred Tax — — — — — — $58.1b ($91.4b) $66.9b $9.8b $52.0b
Equity-settled share-based compensation $15.4b $18.6b $20.1b $29.1b $37.7b $43.4b $60.7b $70.9b $72.9b $72.8b —
Impairment losses $51.4b $13.5b $10.1b $101.9b $25.5b $54.5b $64.4b $150.0b $106.5b $145.7b —
Asset Impairment Charge — — — — — — $64.4b $150.0b $106.5b $145.7b $82.9b
Share of loss (profit) of investments accounted for using the equity method — — $43.6b $24.0b ($76.0m) $15.4b $8.6b ($6.5b) $4.0b $2.2b —
Earnings (Loss)es From Equity Investments — — — — — — $8.6b ($6.5b) $4.0b $2.2b $3.8b
Change In Working Capital — — — — — — ($25.3b) ($256.0b) ($59.4b) $199.9b ($12.9b)
Decrease (increase) in trade and other receivables ($37.3b) ($647.0m) ($13.4b) ($34.8b) ($9.3b) $127.3b $75.1b $15.1b ($59.0b) ($70.2b) —
Change In Receivables — — — — — — $75.1b $15.1b ($59.0b) ($70.2b) $36.9b
Increase in inventories $3.9b $13.7b $58.7b $137.5b $26.0b ($46.1b) ($79.2b) ($115.7b) ($35.0b) ($61.3b) —
Change In Inventory — — — — — — ($79.2b) ($115.7b) ($35.0b) ($61.3b) ($38.0b)
Decrease in trade and other payables $42.6b $6.9b ($16.4b) ($29.9b) $36.6b $125.2b ($84.8b) ($9.9b) ($7.1b) ($3.1b) —
Change In Other Current Liabilities — — — — — — $31.7b ($18.6b) ($3.5b) ($81.6b) ($30.0b)
Cash flows from investing activities:
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $2.6b $3.0b $50.7b $12.6b $46.5b $1.8b $962.0m $8.6b $78.0m $6.5b —
Capital Expenditure — — — — — — ($633.7b) ($480.7b) ($379.6b) ($414.7b) ($301.2b)
Acquisition of investments ($12.1b) ($16.9b) ($17.1b) ($7.6b) ($12.6b) ($8.3b) ($10.2b) ($6.8b) ($97.5b) ($15.9b) —
Proceeds from sales and redemption of investments $5.3b $40.7b $65.0b $49.4b $74.6b $16.9b $22.3b $8.0b $29.4b $7.0b —
Net Other Investing Changes — — — — — — ($3.1b) ($4.0b) ($1.1b) ($2.8b) ($897.0m)
Cash flows from financing activities:
Proceeds From Borrowings Classified As Financing Activities — — $2.8t $496.2b $1.2t $249.3b $75.0b $100.0b $1.0t — —
Repayments Of Borrowings Classified As Financing Activities — — $0 $701.1b $1.7t $810.1b $356.7b $320.9b $1.3t — —
Net increase (decrease) in short-term loans and commercial papers $407.0b ($403.9b) $367.3b ($351.2b) ($149.0b) ($2.0m) $40.0b $277.0b $27.5b ($341.8b) —
Issuance Of Debt — — — — — — $115.0b $377.0b $1.1t $586.1b $700.4b
Long Term Debt Issuance — — — — — — $75.0b $100.0b $1.0t $586.1b $700.4b
Net Issuance Payments Of Debt — — — — — — ($285.1b) $1.5b ($314.3b) $1.1b ($743.9b)
Net Long Term Debt Issuance — — — — — — ($325.1b) ($275.5b) ($341.8b) $342.9b ($742.4b)
Net Short Term Debt Issuance — — — — — — $40.0b $277.0b $27.5b ($341.8b) ($1.5b)
Long Term Debt Payments — — — — — — ($400.1b) ($375.5b) ($1.4t) ($243.2b) ($1.4t)
Repayment Of Debt — — — — — — ($400.1b) ($375.5b) ($1.4t) ($585.0b) ($1.4t)
Short Term Debt Payments — — — — — ($2.0m) — — — ($341.8b) ($341.8b)
Repurchase Of Capital Stock — — — — — — ($26.9b) ($2.3b) ($51.9b) ($51.6b) ($101.6b)
Net Common Stock Issuance — — — — — — ($26.9b) ($2.3b) ($51.9b) ($51.6b) ($101.6b)
Common Stock Payments — — — — — — ($26.9b) ($2.3b) ($51.9b) ($51.6b) ($101.6b)
Common Stock Dividend Paid — — — — — ($283.7b) ($279.4b) — — — —
Dividends paid ($141.7b) ($141.9b) $142.9b $282.8b $283.8b $284.2b $278.3b $287.8b $303.2b ($311.9b) ($309.7b)
Dividends Paid Classified As Financing Activities — — $143.0b $282.6b $283.4b $283.7b $279.4b $287.2b $302.5b — ($309.7b)
Dividends received $3.7b $7.7b $2.7b $1.4b $387.0m $3.4b $3.6b $13.2b $635.0m $1.3b $679.0m
Cash Dividends Paid — — — — — — ($279.4b) ($287.2b) ($302.5b) ($311.9b) ($309.7b)
Net Other Financing Charges — — — — — — ($9.2b) $34.0b $30.2b ($13.0b) ($13.3b)
Net increase (decrease) in cash and cash equivalents ($104.4b) ($41.7b) $439.0b ($43.3b) $316.1b ($145.3b) ($339.1b) ($101.9b) ($61.3b) $175.5b —
Beginning Cash Position — — — — — — $849.7b $533.5b $457.8b $385.1b $350.0m
Cash and cash equivalents at the beginning of the year $319.5b $294.5b $702.1b $637.6b $966.2b $849.7b $533.5b $457.8b $385.1b $595.1b —
Effects of exchange rate changes on cash and cash equivalents ($5.7b) ($4.6b) ($31.3b) ($21.8b) $12.5b $28.8b $22.9b $26.2b ($11.4b) $34.5b —
Effect Of Exchange Rate Changes — — — — — — $22.9b $26.2b ($11.4b) $34.5b $34.5b
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Financial Items
Adjustments For Current Tax Of Prior Period — — ($10.9b) ($4.7b) ($12.2b) ($11.3b) ($17.5b) ($5.0b) ($4.7b) — —
Adjustments For Finance Income — — ($66.4b) — — — — — — — —
Adjustments For Unrealised Foreign Exchange Losses Gains — — ($2.7b) $399.0m $0 $0 — — — — —
Goodwill — — $4.2t $4.0t $4.0t $4.4t $4.8t $5.4t $5.3t — $82.9b
Payments Of Lease Liabilities Classified As Financing Activities — — — $30.0b $39.3b $39.7b $43.4b $54.6b $45.2b — —
Payments To Acquire Or Redeem Entitys Shares — — $1.2b $3.7b $2.1b $77.5b $26.9b $2.3b $51.9b — —
Purchase Of Intangible Assets Classified As Investing Activities — — $56.4b $90.6b $125.3b $62.8b $493.0b $305.3b $147.0b — —
Purchase Of Interests In Associates — — — — — — — — $1.0b — —
Net profit (loss) for the year $115.5b $186.7b $109.0b $44.3b $376.2b $230.2b $317.0b $144.2b $108.1b ($152.1b) —
Change in fair value of financial assets and liabilities associated with contingent consideration arrangements, net ($18.4b) $10.5b ($6.0b) ($18.4b) $59.3b ($11.2b) $4.0b $20.8b ($602.0m) $1.0b —
Finance (income) and expenses, net — — $66.4b $137.2b $143.1b $142.9b $106.8b $167.8b $163.5b $146.4b —
Increase (decrease) in provisions $20.5b ($6.5b) $47.1b $21.9b $49.1b ($58.1b) $31.9b ($126.9b) $45.2b $416.1b —
Decrease in other financial liabilities — — ($4.0b) $7.2b $173.4b ($49.6b) $31.7b ($18.6b) ($3.5b) ($81.6b) —
Settlement of forward exchange contracts, net — — — — — — — ($46.6b) $5.9b $129.7b —
Other, net ($4.9b) ($4.1b) ($14.3b) ($3.9b) ($172.0m) ($385.0m) ($9.2b) ($26.1b) ($16.6b) ($13.0b) —
Cash generated from operations $302.1b
$407.7b +34.96%
$373.4b -8.42%
$896.5b +140.10%
$1.2t +35.26%
$1.3t +4.20%
$1.2t -7.95%
$918.4b -21.04%
$1.2t +31.49%
$1.2t +0.53%
—
Tax refunds and interest on tax refunds received $12.5b $25.0b $6.6b $7.8b $34.1b $7.3b $12.5b $17.9b $20.2b $7.8b —
Interest received $2.0b $2.4b $6.3b $11.5b $1.1b $2.9b $5.1b $11.2b $17.7b $17.4b $18.2b
Acquisition of intangible assets ($50.4b) ($61.3b) ($56.4b) ($90.6b) ($125.3b) ($62.8b) ($493.0b) ($305.3b) ($147.0b) ($234.9b) —
Acquisition of option to license — — — — — — $0 $0 ($31.8b) ($3.7b) —
Acquisition of shares in associates — — — — — — $0 $0 ($1.0b) ($623.0m) —
Proceeds from sales of shares in associates — — — — — — $0 $0 $57.7b $880.0m —
Settlement of forward exchange contracts designated as net investment hedges, net — — — — — $0 $0 ($33.3b) ($13.8b) ($1.5b) —
Proceeds from issuance of bonds and long-term loans $260.2b $393.5b $2.8t $496.2b $1.2t $249.3b $75.0b $100.0b $1.0t $586.1b —
Repayments of bonds and long-term loans ($191.8b) ($140.0b) $0 ($701.1b) ($1.7t) ($810.1b) ($356.7b) ($320.9b) ($1.3t) ($200.4b) —
Settlement of cross currency interest swaps related to bonds and loans — — — — — $0 $0 $60.1b $46.9b $0 —
Acquisition of treasury shares ($23.1b) ($18.8b) ($1.2b) ($3.7b) ($2.1b) ($77.5b) ($26.9b) ($2.3b) ($51.9b) ($51.6b) —
Repayments of lease liabilities — — ($1.7b) ($30.0b) ($39.3b) ($39.7b) ($43.4b) ($54.6b) ($45.2b) ($42.8b) —
Cash Flow From Continuing Financing Activities — — — — — — ($709.1b) ($354.4b) ($751.4b) ($496.8b) ($1.3t)
Cash Flow From Continuing Investing Activities — — — — — — ($607.1b) ($463.9b) ($367.1b) ($369.1b) ($243.6b)
Change In Other Working Capital — — — — — — $31.9b ($126.9b) $45.2b $416.1b $15.6b
Change In Payable — — — — — — ($84.8b) ($9.9b) ($7.1b) ($3.1b) $2.6b
Changes In Cash — — — — — — ($339.1b) ($101.9b) ($61.3b) $175.5b $175.4b
End Cash Position — — — — — — $533.5b $457.8b $385.1b $595.1b $175.7b
Financing Cash Flow — — — — — — ($709.1b)
($354.4b) +50.02%
($751.4b) -112.02%
($496.8b) +33.88%
($1.3t) -158.18%
Free Cash Flow — — — — — — $343.5b $235.6b $677.6b $626.8b $626.7b
Gain Loss On Investment Securities — — — — — — — ($46.6b) $5.9b $129.7b $129.7b
Gain Loss On Sale Of Business — — — — — — ($6.8b) ($7.8b) ($10.2b) ($18.3b) ($21.9b)
Gain Loss On Sale Of PPE — — — — — — $10.0m $6.1b $4.5b $3.1b $3.0b
Investing Cash Flow — — — — — — ($607.1b) ($463.9b) ($367.1b) ($369.1b) ($243.6b)
Net Business Purchase And Sale — — — — — — $8.0b $20.0b $77.2b $33.6b $103.6b
Net Intangibles Purchase And Sale — — — — — — ($493.0b) ($305.3b) ($178.8b) ($238.7b) ($109.9b)
Net PPE Purchase And Sale — — — — — — ($139.7b) ($166.8b) ($200.7b) ($169.5b) ($184.8b)
Operating Gains Losses — — — — — — $1.8b ($54.8b) $4.2b $116.7b ($15.1b)
Other Non Cash Items — — — — — — $18.0b $206.8b $147.5b $99.1b —
Purchase Of Business — — — — — — $0 $0 ($1.0b) ($623.0m) ($623.0m)
Purchase Of Intangibles — — — — — — ($493.0b) ($305.3b) ($178.8b) ($238.7b) ($109.9b)
Purchase Of PPE — — $77.7b $127.1b $111.2b $123.3b ($140.7b) ($175.4b) ($200.8b) ($176.0b) ($301.2b)
Sale Of Business — — — — — — $8.0b $20.0b $78.2b $34.2b $104.6b
Sale Of PPE — — — — — — $962.0m $8.6b $78.0m $6.5b $6.5b
Stock Based Compensation — — — — — — $60.7b $70.9b $72.9b $72.8b $74.0b
Unrealized Gain Loss On Investment Securities — — — — — — $4.0b $20.8b ($602.0m) $1.0b $174.0m
Net Investment Purchase And Sale — — — — — — $12.1b ($32.0b) ($81.9b) ($10.4b) ($70.4b)
Purchase Of Investment — — — — — — ($10.2b) ($40.1b) ($111.4b) ($17.4b) ($95.6b)
Sale Of Investment — — — — — — $22.3b $8.0b $29.4b $7.0b $25.3b
Gain on divestment of business and subsidiaries ($115.4b) ($134.1b) ($83.0b) ($16.8b) ($230.0b) ($7.8b) ($6.8b) ($7.8b) ($10.2b) ($18.3b) —
Proceeds from sales of business, net of cash and cash equivalents divested $64.4b $85.1b $85.1b $461.5b $530.4b $28.2b $8.0b $20.0b $20.6b $33.3b —
Change In Cash Supplemental As Reported — — — — — — ($339.1b) ($101.9b) ($61.3b) $175.5b —
Interest Paid Classified As Financing Activities ($7.0b) ($8.4b) $34.9b $11.8b $107.3b $108.2b $108.6b $100.4b $113.0b ($121.4b) —
Income taxes paid ($53.2b) ($54.9b) ($51.5b) ($234.6b) ($235.8b) ($147.7b) ($198.4b) ($219.9b) ($170.6b) ($180.4b) —

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.